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SIGNIFICANCE
Actinic cheilitis is a condition involving mainly the lower lip 
that is generally considered a superficial form of squamous 
cell carcinoma. Chronic sun exposure is a recognized risk 
factor for actinic cheilitis development. The prevalence of 
this disease in Europe is not known. We report the first 
multicenter prevalence study of actinic cheilitis. The di-
sease was present in almost one third of the screened 
population ≥45 years. Significant and independent risk 
factors were age ≥60 years, fair skin (Fitzpatrick skin pho-
totype II), outdoor working for more than 25 years and 
history of non melanoma skin cancer. 
Actinic cheilitis is thought to be a premalignant lesion 
or a superficial squamous cell carcinoma. The preva-
lence of actinic cheilitis in Europe is unknown. The aim 
of this study was to determine the prevalence of ac-
tinic cheilitis in the Galicia region (north-west Spain). 
Secondary objectives were the description of risk fac-
tors of actinic cheilitis. A cross-sectional multicentre 
study in patients ≥ 45 years of age was performed in 
8 dermatology departments in Galicia region during a 
1-year period. The prevalence of actinic cheilitis was 
31.3%. Significant and independent risk factors of ac-
tinic cheilitis after multivariate analysis were age ≥ 60 
years, Fitzpatrick skin phototype II, outdoor working 
for more than 25 years, and previous history of non-
melanoma skin cancer. This is the first cross-sectional 
multicentre study of the prevalence of actinic cheilitis 
in Europe. Actinic cheilitis was present in almost one-
third of the screened patients. Lip examination should 
be performed in all patients with chronic actinic da-
mage.
Key words: actinic cheilitis; prevalence; epidemiology.
Accepted Aug 7, 2018; Epub ahead of print Aug 7, 2018
Acta Derm Venereol 2018; 98: 970–974.
Corr: Isabel Rodríguez-Blanco, Dermatology Department, Hospital da 
Barbanza-Hospital Gil Casares, C/Choupana s/n, ES-15706, Santiago de 
Compostela (La Coruña), Spain. E-mail: sabeblanco@gmail.com
Actinic cheilitis (AC) is the most common denomina-tion for a condition with clinical and histological 
changes due to chronic solar exposure, mainly involving 
the lower lip (1). Similarly to actinic keratosis (AK) of the 
skin, AC is considered to be a potentially malignant oral 
lesion (2) or even a lip in situ squamous cell carcinoma 
(SCC) (1, 3, 4).
Diagnosis and treatment of AC can be challenging; 
it has been shown that the clinical appearance of AC 
correlates poorly with the degree of dysplasia (5–9), 
thus clinicians have little evidence about the severity of 
the disease. The accuracy of diagnosis can be increased 
with new imaging techniques, such as dermoscopy, with 
the presence in AC of ill-demarcated borders, vascular 
telangiectasia, white-coloured projections and island-like 
structures around the ulcerous areas (10), or confocal mi-
croscopy (11). Performing a biopsy is mandatory in cases 
of doubtful lesions. Furthermore, the response to therapy 
is commonly unsatisfactory, with frequent recurrences.
There have been few epidemiological studies of AC 
compared with those related to AK; prevalence data of 
AC proceed from heterogeneous epidemiological studies 
performed in specific populations, mainly in South Ame-
rica (12–25), thus the prevalence in Europe has not been 
established, since multicentre, well-designed prevalence 
studies have not been performed.
The rate of progression of AC to an invasive SCC is 
unknown. Since the lip has traditionally been considered 
a high-risk location for SCC, knowledge of risk factors 
is of great importance.
The main objective of the present study was to deter-
mine the prevalence of AC in the Galicia region of Spain. 
Secondary objectives were: (i) to describe risk factors 
for AC in our study population; and (ii) to establish the 
clinical and epidemiological profile of patients with AC.
METHODS
A cross-sectional multicentre study was conducted in Galicia 
(total population in 2016: 2,718,525; data from Galician Statistics 
Institute, http:www.ige.eu), a region located in north-west Spain. 
Consecutive patients attending a general dermatology outpatient 
clinic were recruited once a week from 12 January 2016 to 31 
January 2017, by 8 dermatology consultants, located in 8 different 
hospitals. Only patients ≥ 45 years of age attending as a “First 
Visit”, who signed the informed consent were included. A “First 
Visit” was defined as: (i) a patient who was seen for the first time 
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at that particular dermatology department; or (ii) a patient who 
had visited that dermatology department previously, but had been 
discharged. Patients who were not able to understand or answer 
the questions regarding clinical history were excluded. Data from 
each patient were collected by the dermatologists in a general form 
(Screening Form) and after clinical examination (naked eye and/or 
magnifying glasses), data from patients with AC were completed 
in an extra and detailed questionnaire (AC Form).
In a preliminary analysis, when 250 cases were reached, the 
prevalence of patients with AC was slightly higher than 30%, 
so a sample size calculation was performed using a formula to 
assess a proportion in a statistically infinite population, establish­
ing a sample of approximately 1,200 cases that demonstrated a 
prevalence of approximately 30% with a standard error between 
2.5% and 2.6%. Thus, more than 300 cases of patients with AC 
were recruited, increasing the statistical power of the comparisons 
between this subsample and the one without AC. 
A descriptive analysis was performed for all the collected vari-
ables. Categorical variables were presented as a list of frequencies 
and proportions. In case of quantitative variables (continuous or 
ordinal) central tendency estimators, such as means, median and 
mode, and dispersion measures (standard deviation [SD] and 
maximum-minimum values) were calculated.
The study population was biased, with a greater presence of wo-
men and elderly subjects. In order to correct this bias, the screening 
sample was weighted according to the age and sex distribution 
for the Galician population over 45 years old in 2016 (source: 
Instituto Galego de Estatistica, https://www.ige.eu/web/index.
jsp) using the raking ratio estimation method (26). This method 
is used to adjust the sampling weights of the sample data based 
on known population characteristics when they are more than one.
Clinical characteristics of AC, classification of Fitzpatrick’s skin 
type (27) and standardization of each hair and eye colour were 
precisely specified in a previous meeting by all the investigators, 
in order to minimize inter-observer bias. All the investigators were 
dermatologists with expertise in actinic damage and skin cancer. 
AC was defined by the presence of one or several of the following 
items (modified from Ribeiro et al. (22)): persistent desquamation, 
persistent erythema, mottled appearance (erythema and white 
patches), plaque (solid, raised, flat lesion > 1 cm) and/or erosion/
ulceration that could not be attributed to other dermatological 
disorders. All patients were treated according to European Guide-
lines for the evaluation and treatment of AK (28), and those with 
uncertain lesions were biopsied according to clinicians’ criteria; 
therefore, those with uncertain eroded/ulcerated lesions (n = 7) 
were biopsied excluding SCC. Those patients with infiltrated 
erosions/ulcerations or tumour lesions, in which a firm suspicion 
of SCC was raised, were biopsied or completely excised and not 
included in the study.
The study protocol was approved by the Research Ethics Com-
mittee of Pontevedra-Vigo-Ourense, Spain (protocol number 
2015/582).
All statistical analyses were performed using SPSS 22.0 statis-
tical software for Windows.
RESULTS
A total of 1,250 patients were selected for the study, 11 
of whom declined to participate in the study or to sign 
the consent form; therefore a total of 1,239 patients 
completed the Screening Form. 
Data for the total and AC population of the study 
regarding age, sex distribution, tobacco consumption, 
Fitzpatrick skin type, outdoor working for more than 25 
years and history of non-melanoma skin cancer (NMSC) 
are showed in Table SI1. Additional demographic and 
clinical data for the AC population are shown in Table I.
The mean ± SD age of the total sample was 65.8 ± 11.9 
years (range 45–96 years). Women accounted for 59.1% 
and 40.9% were men. Previous or current smoking 
history was reported by 38.4% of patients. All patients 
Table I. Summary table for patients with actinic cheilitis (AC) 
Characteristics
Hair colour, n (%)
  Blonde 85 (20.8)
  Red 1 (0.2)
  Brown 256 (62.7)
  Black 66 (16.2)
Eye colour, n (%)
  Light 197 (48.3)
  Dark 211 (51.7)
Outdoor occupation, n (%)
  No 104 (25.5)
  Yes 304 (74.5)
Previous history of NMSC, n (%)
  No 327 (79.8)
  Yes 83 (20.2)
Previous NMSC type, n (%)
  BCC 49 (59)
  SCC 30 (36.2)
  BCC + SCC 4 (4.8)
SCC located at the lip, n (%)
  No 32 (94.1)
  Yes 2 (5.9)
Previous skin melanoma, n (%)
  No 403 (98.7)
  Yes 5 (1.3)
Present or past tobacco consumption, n (%)
  No 271 (66.4)
  Yes 137 (33.6)
Duration of active smoking, years, mean ± SD 29.8 ± 14.04
Smoking other than cigarettes (pipe or cigars), n (%)
  No 128 (93.4)
  Yes 9 (6.6)
Weekly recommended alcohol intake exceeded, n (%)
  No 362 (88.7)
  Yes 46 (11.3)
Immunosuppressed, n (%)
  No 395 (96.8)
  Yes 13 (3.2)
Immunosuppression type, n (%)
  Pharmacological 6 (46.2)
  Oncological 7 (53.8)
Location of AC, n (%)
  Inferior lip 326 (79.9)
  Superior lip 4 (1.0)
  Both 78 (19.1)
AC cause of seeking dermatological consultation, n (%)
  No 394 (96.6)
  Yes 14 (3.4)
Previous visit to dermatologist in relation to AC, n (%)
  No 396 (97)
  Yes 12 (3)
Lips treated in the past by a dermatologist, n (%)
  No 392 (96.1)
  Yes 16 (3.9)
Treatment in the past by a dermatologist, n (%)
  No treatment 392 (96.2)
  Cryotherapy 12 (3.0)
  Laser 1 (0.2)
  Others 1 (0.2)
  Cryotherapy + laser + surgery 1 (0.2)
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were Caucasians and Fitzpatrick type III was the most 
prevalent (52%), followed by type II (30.8%) and type 
IV (16.2%); types I and V were barely represented (0.6% 
and 0.5%, respectively) and no patients with phototype 
VI were present. Outdoor working for more than 25 
years was reported by 39.7% of the patients and previous 
NMSC was present in 11.6% of the population.
In relation to the AC population, mean age was 71.9 
years (SD 10.47, range 45–96 years) and regarding sex 
distribution, 55.4% were female and 44.6% were male. 
Most of AC population had skin phototype III (46.8%) 
or II (45.6%), followed by IV (7.1%) and I (0.5%). Both 
hair and eye colour were also analysed; brown hair was 
present in 62.7% of the population, followed by blonde 
hair (20.8%), black hair (16.2%) and red hair (0.2%), 
and 48.3% had light eye colour. Outdoor occupation 
was reported by 74.5% of the AC patients and 96.4% 
of them had worked outdoors for more than 25 years. 
Previous history of NMSC (confirmed by reviewing 
medical records or by a medical report from another cen-
tre supplied by the patient) was present in 20.2%, being 
basal cell carcinoma the most frequent (59%), followed 
by SCC (36.2%) and a combination of both (4.8%); in 
5.9% of the patients with previous SCC, this carcinoma 
was located at the lip. Only 1.3% of the AC population 
had a previous skin melanoma. Present or past tobacco 
consumption was present in 33.6% of the patients with 
AC and the mean duration of active smoking was 29.8 
years; only 6.6% had the habit of smoking other than 
cigarettes (pipe or cigars). Weekly recommended alcohol 
consumption (no more than 14 units during a week) was 
exceeded by 11.3%. Just 3.2% of AC patients were im-
munosuppressed, either related to oncological (53.8%) 
or pharmacological causes (46.2%). Location of AC was 
mainly at the inferior lip (79.9%), followed by both lips 
(19.1%) and only 1% at the superior lip. The reason for 
seeking dermatological consultation was the lip symp-
toms in only 3.4% of the AC patients; 3% had visited a 
dermatologist in the past in relation to a lip problem and 
3.9% had their lips previously treated by a dermatologist 
(using cryotherapy, laser, surgery or others). 
A total of 410 out of 1,239 patients were diagnosed 
as having AC and complete data were available in 408 
patients. The prevalence of AC in the study population 
was found to be 33.1% (95% confidence interval (95% 
CI) 30.5–35.7). This result was corrected after weighting 
the total population of the study with data using Rake’s 
Ponderation method corresponding to age and sex distri-
bution of Galician population from 45 years old onwards 
(year 2016, data from Galician Statistics Institute, www.
ige.eu), being 31.3% (95% CI 28.7–33.8).
Univariate and multivariate analysis of the different 
variables are showed in Fig. S11. In univariate analysis, 
odds ratio (OR) related to female sex and tobacco con-
sumption were 0.795 (95% CI 0.626–1.01, p = 0.06) and 
0.77 (95% CI 0.6–0.99, p = 0.041), respectively, but after 
multivariate analysis these OR changed to 1.21 (95% 
CI 0.86–1.69, p = 0.27) and 1.36 (95% CI 0.96–1.93, 
p = 0.088), remaining the rest variables with minor chan-
ges (Fig. 1). Significant and independent risk factors of 
AC after multivariate analysis were age ≥ 60 years (from 
60–69 years OR 4.07, p < 0.001; from 70–79 years OR 
6.4, p < 0.001; from 80–89 years OR 9.46, p < 0.001; for 
older than 90 years OR 8.64, p = 0.004), Fitzpatrick skin 
phototype II (OR 2.94, p < 0.001), outdoor working for 
more than 25 years (OR 7.1, p < 0.001) and history of 
NMSC (OR 1.75, p = 0.012).
DISCUSSION
The oncogenic potential of chronic sun-exposed skin is 
a major concern (4). AC is considered to be the lip coun-
terpart of AK, with some peculiarities: the anatomical 
position and prominent shape of the lips make them more 
susceptible to UV radiation, mainly the lower lip, and to 
irritants, trauma or virus infections. The skin type of the 
vermillion is described as a transition between buccal 
mucosa and normal skin (3) and has a thinner epithelium 
that lacks keratin covering, with less melanin and fewer 
secretions from the sebaceous and sweat glands (6), all 
these features contributing to the increased susceptibility 
to solar radiation. Moreover, not only is AC a very well-
known risk factor for the development of invasive SCC, 
but the lip has traditionally been considered a high-risk 
location for SCC. 
The prevalence of AC in our study was 31.3%. The 
AC prevalence data described in the literature comprise a 
wide range, between 0.9% and 43.24% (12–25), and the-
se differences could be related to the non-homogeneous 
clinical definition of AC and to the different inclusion 
criteria. Moreover, the majority of these studies were 
performed in selected populations, such as fishermen, 
sugar-cane collectors and rural workers from very spe-
cific geographical locations, lacking the advantages of 
a multicentre cross-sectional study. In addition, relevant 
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data, such as Fitzpatrick skin type, previous solar expo-
sure, photoprotective measures, history of NMSC and 
previous lip interventions were not properly collected. 
Therefore, transferring their results in terms of prevalen-
ce to the general population should be done with caution, 
as significant bias cannot be excluded. We consider that 
our study provides reliable data for AC prevalence, since 
it has been performed in 8 different hospitals, including 
patients selected only for the fact that they had arranged 
an appointment with a general dermatologist. 
The high prevalence of AC in our study could be due 
to several reasons; one of them is the increasing median 
age of Galician population. Ageing is a major concern in 
terms of public health in industrialized countries. In 2016, 
population 65 years or older accounted for 24.31% in 
Galicia (data from Galician Statistics Institute, http:www.
ige.eu), being one of the regions with the highest pro-
jected old-age dependency ratio in 2050 (29). Finally, 
another factor that may have influenced the results is the 
inclusion of early stages of the disease, such as persistent 
desquamation and persistent colour changes that could 
not be explained by other dermatological disorders; this 
allowed us to include even most incipient forms of AC.
A significant and independent correlation was found 
between age ≥ 60 years and AC, and the risk highly 
increased as age progressed. Significant association 
with ageing has been present in other studies (19, 21, 
22) confirming that accumulation of sun exposure is 
the main risk factor for AC. This statement is further 
corroborated by the significant correlation between AC 
and outdoor working for more than 25 years (OR 7.14), 
being the relation with accumulated time of UV expo-
sure also reported by other authors (18, 19, 22, 23, 25). 
Fitzpatrick phototype II was significantly related to AC 
presence (OR 2.94); this is coherent with previous AC 
prevalence studies that found a significant correlation 
with light/fair skin or white/Caucasian race (18–23, 25). 
No reliable data could be obtained regarding Fitzpatrick 
skin phototype I, since only 7 patients were screened 
and only 2 patients belonged to the AC positive subco-
hort. This is the first prevalence study of AC to specify 
Fitzpatrick’s classification of patients and data related 
to eye and hair colour. A significant correlation between 
history of NMSC and AC was described herein and no 
previous AC prevalence studies had analysed this be-
fore. This finding is consistent, as solar exposure is an 
important risk factor for AC and NMSC, mainly SCC, 
so AC should be ruled out in all patients with NMSC as 
part of routine dermatological exploration, in order to 
diagnose early stages.
The rest of the analysed variables were not significant. 
Sex distribution showed a high proportion of females 
in both the screening and the AC population (59.1% 
and 55.4%, respectively) and this could be related to 
the higher tendency of women to seek dermatological 
consultation compared with men (30); in contrast, other 
AC prevalence studies showed a clear superiority of 
men (15, 16, 18, 19, 23, 25) and the reasons the authors 
gave for that finding were that women often use lipsticks 
providing a physical block against UV radiation, have a 
bigger tendency to use a sunscreen and are less frequently 
engaged in outdoor activities. Furthermore, an important 
percentage of the AC prevalence studies were performed 
in specific populations with professional activities that 
clearly have a male predominance (fishermen, sugar­
cane collectors, farmers, rural workers). Tobacco has a 
well-documented dose-response relationship with deve-
lopment of oral cancer (31) and lip cancer, especially in 
patients with the habit of leaving the cigarette on the lip 
while smoking (32). No relation between tobacco con-
sumption and AC was found in our study and the same 
happened in all AC prevalence studies that specifically 
investigated this correlation (15, 18–22) or other AC 
retrospective studies (9) with the exception of Campisi 
& Margiotta (13) who described in 5 patients with AC a 
significant association with both tobacco smoking and 
alcohol drinking, but not separately. The influence of 
smoking in the development of AC has been controver-
sial, but a causative relation has not been established 
(3), even when it is evident that constant exposure to 
heat generated by smoke combustion may aggravate 
the clinical aspect of the disease in individuals who are 
also exposed to solar radiation (3, 7, 19, 22). Alcohol 
drinking was correlated with AC in one study (19) in 
which the daily/weekly intake was not specified, as in 
the aforementioned study by Campisi & Margiotta (13). 
Consistent with all prevalence studies, AC was located 
predominantly on the inferior lip and only 4 patients in 
our study (1%) had only superior lip affection, but all of 
them had had their inferior lip treated previously (2 with 
laser and 2 with surgical excision).
Limitations
The present study has some limitations; one is related to 
its cross-sectional design in which the evolution is not 
analysed. In addition, the diagnosis was based on clinical 
features in more than 98% of cases and only 7 patients 
with uncertain lesions (1.71% of the AC population) were 
biopsied, being the clinical suspicion of AC confirming 
the clinical suspicion of AC in all of them. Although 
this is the first study of AC prevalence to assess the 
time period of tobacco consumption, a more accurate 
quantification could be made using the determination of 
pack-years instead of years of active smoking.
Only patients aged 45 years and over were selected for 
the study, as there is agreement that most cases occur in 
people over 50 years of age (6, 7, 19, 33); however, this 
could exclude younger patients with AC. The fact that 
the study was performed in an outpatient dermatology 
clinic setting may add some bias, as the higher proportion 
of female patients probably related to the aforementio-
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Only patients attending as a “First Visit” were allowed 
to participate, excluding those who were followed up for 
other reasons, including AC, NMSC or others. Finally, 
even though a precise definition of AC was established 
before starting the study and all investigators were der-
matologists with broad experience, inter-observer bias 
cannot be completely ruled out.
Conclusion
The first cross­sectional multicentre AC prevalence study 
is presented herein. As all previous prevalence studies, 
except for one in Sicily (13), were performed in South 
America, a close correlation with a European prevalence 
of AC in the Caucasian population aged 45 years and 
over should be expected. The high prevalence rates of 
AC documented in this study should alert public health 
authorities and clinicians to promote both primary and 
secondary prevention strategies. Photoprotective measu-
res, long-term follow up and histopathological studies of 
suspicious lesions are recommended in order to decrease 
the potential progression of AC to invasive SCC.
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